Sponsor study identifier
Secondary identifiers
NIH
observational
171
1 country
1
Study Start
May 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
May 15, 2018
Actual (reported)Study Completion
September 5, 2018
Actual (reported)This study is designed to understand the impact of glycemic control in patients with type 2 diabetes on dental implants under long-term function. It is hypothesized that poor glycemic control will not have significant effects on implant-related outcomes over longer periods of time.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 5, 2018
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2014
Date type not reportedThis date has not been verified as actual or estimated.
September 15, 2014
Actual (reported)November 4, 2014
Actual (reported)May 15, 2018
Actual (reported)September 5, 2018
Actual (reported)implant complications
long-term clinical evaluations will be performed every 6 months. biologic complications assessed will include signs of infection, inflammation, bone loss, and implant failure.
at an anticipated average of 5 years following placement
resonance frequency analysis
at an anticipated average of 5 years following placement
patients without diagnosed type 2 diabetes, having an HbA1c level below 6.0%
patients diagnosed with type 2 diabetes of over 1 year duration.
Patients will include those edentulous patients benefiting from mandibular implant overdenture support. It may include those already being followed in a similar study or patients newly receiving dental implants. It will also include type 2 diabetes patients who received dental implant therapy as part of a previous study on the impact of glycemic control.
University of Texas Health Science Center At San Antonio
San Antonio, Texas, 78229-3900, United States
thomas oates, dmd, phd
University of Texas Health Science Ctr a
171 participants (actual enrollment reported by the registry).
First Submitted
September 15, 2014
First Posted
November 4, 2014
Study Start
May 2014
Date type not reportedThis date has not been verified as actual or estimated.
Effect of Farxiga on Renal Function and Size in Type 2 Diabetic Patients With Hyperfiltration
Contact the study team to confirm eligibility.
Primary Completion
May 15, 2018
Actual (reported)Study Completion
September 5, 2018
Actual (reported)Last Updated
January 21, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: